The TP53-mediated cell proliferation and migration and apoptosis in bladder cancer were suggested to be modulated by XIST-related inhibition of TET1 binding to TP53 promoter, resulting in hypermethylation and decreased expression of this tumor suppressor gene [198]. This evidence concerns the gene TP53 and urinary bladder cancer.